Format

Send to

Choose Destination
See comment in PubMed Commons below
Oncoimmunology. 2013 Apr 1;2(4):e23660.

The CCL5/CCR5 axis promotes metastasis in basal breast cancer.

Author information

1
Departamento de Farmacología; Facultad de Medicina; Universidad Nacional Autónoma de México; Mexico DF, México.

Abstract

Recently, we have shown that the CCL5/CCR5 axis is active in patients affected by an aggressive basal subtype of breast cancer. Using preclinical models, we have demonstrated that CCR5 promotes breast cancer invasiveness and metastatic potential, while CCR5 inhibition abrogates them. Thus, CCR5 antagonists may constitute an alternative therapeutic approach for patients affected by metastatic basal breast cancer.

KEYWORDS:

CCL5; CCR5; Maraviroc; Vicriviroc; basal breast cancer; metastasis

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis Icon for PubMed Central
    Loading ...
    Support Center